Oct 21, 2016
10:1
For every share held, investors received 10. The price per share adjusted from $2.92 to $0.29.
The split itself did not change the total investment value.
PROTO SCRIPT PHARMACEUTICAL CORP (OTC:PSCR) operates in the Engineering & construction industry.
PROTO SCRIPT PHARMACEUTICAL CORP company overviewPROTO SCRIPT PHARMACEUTICAL CORP's most recent stock split was on October 21, 2016. It was a 10-for-1 forward split, so shareholders received 10 shares for every share they held.
PROTO SCRIPT PHARMACEUTICAL CORP has split its stock once. This history records one forward split, on October 21, 2016.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In PROTO SCRIPT PHARMACEUTICAL CORP's 10-for-1 split on October 21, 2016, every share became 10 shares.
PROTO SCRIPT PHARMACEUTICAL CORP has not announced a new split in our records. Its most recent split was on October 21, 2016, 10 years ago. Companies announce splits in advance, and any new OTC:PSCR split will appear on this page.